Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Tax Provisions (2014 - 2025)

Scynexis' (SCYX) quarterly Tax Provisions came in at -$1.8 million in Q4 2025, up 60.46% on a YoY basis from -$1.1 million in Q4 2024, and up 60.46% quarter-over-quarter from -$4.6 million in Q4 2024.

Analysis

Scynexis (SCYX) Tax Provisions (2014 - 2025) Analysis & Trends

Scynexis (SCYX) has reported Tax Provisions for 8 consecutive years, with -$1.8 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Tax Provisions rose 60.46% year-over-year to -$1.8 million; the trailing twelve-month figure through Dec 2025 stood at -$1.8 million (up 59.24% YoY), and the FY2025 full-year result was -$1.8 million, up 59.32% from the prior year.
  • Tax Provisions grew to -$1.8 million in Q4 2025 per SCYX's latest filing, from -$4.6 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $14.1 million in Q4 2023 and bottomed at -$8.5 million in Q4 2022.
  • Historically, Tax Provisions has averaged -$1.2 million across 5 years, with a median of -$1.8 million in 2025.
  • The sharpest annual moves came in 2022 and 2023: Tax Provisions slumped 527.27% in 2022, then jumped 266.45% in 2023.
  • Over 5 years, Tax Provisions stood at -$4.7 million in 2021, then sank by 80.61% to -$8.5 million in 2022, then surged by 266.45% to $14.1 million in 2023, then tumbled by 132.37% to -$4.6 million in 2024, then jumped by 60.46% to -$1.8 million in 2025.
  • According to Business Quant data, Tax Provisions over the past three periods registered -$1.8 million, -$4.6 million, and -$395000.0 for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 393.00 Mn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 242.00 Mn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 292.00 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 230.90 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -59.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 15.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 13.31 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 34.90 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 1.90 Mn
10 Scynexis 52.73 Mn -61.96 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.81 Mn
Dec 31, 2024 -4.57 Mn
Sep 30, 2024 -395,000.00
Mar 31, 2024 531,000.00
Dec 31, 2023 14.11 Mn
Dec 31, 2022 -8.48 Mn
Mar 31, 2022 -4.70 Mn
Dec 31, 2021 -4.69 Mn
Sep 30, 2021 -50,000.00
Jun 30, 2021 -4.14 Mn
Mar 31, 2021 1.10 Mn
Dec 31, 2020 -9.11 Mn
Jun 30, 2020 -3.14 Mn
Dec 31, 2019 -11.28 Mn
Dec 31, 2014 -257,000.00
Sep 30, 2014 -338,000.00